1. THE NATIONAL LYMPHEDEMA NETWORK:  The National Lymphedema Network is an all inclusive resource for patients with lymphedema. It includes education, resources, patients stories, outreach and connection with other lymphedema patients and information and links on supplies for lymphedema patients and clinical trials.

2. AMERICAN CANCER SOCIETY: Information for patients considering surgical intervention for breast cancer and including the risk of lymphedema and post-surgical instructions.

3. MAYO CLINIC LYMPHEDEMA RESOURCES: Information for patients regarding lymphedema and treatments.

4. LYMPHEDEMA BLOG: Contains important information and updates regarding lymphedema.

5. LYMPHNOTES: Comprehensive resource for lyphdema patients.


1. FISTULA FIRST:  A site with many resources for patients with Chronic Kidney Disease, aimed at educating and tracking the progress of national efforts to use fistula as a first access source for patients with kidney disease needing percutaneous access.  This site helps you find a surgeon skilled in AV fistula placement, provides educational resources regarding chronic kidney disease (CKD) and provides data and tracks regional efforts of the End Stage Renal Disease (ESRD) Networks.

2. NATIONAL CHRONIC KIDNEY DISEASE FOUNDATION: The National Chronic Kidney Disease Foundation provides a wealth of educational and outreach resources for patients, family, providers and researchers who are affected by Chronic Kidney Disease.

3. NATIONAL KIDNEY FOUNDATION KIDNEY DISEASE OUTCOME QUALITY INITIATIVE (NKF K/DOQI) 2000: Year 2000 guidelines and evidence for interventions in patient with chronic kidney disease.

 4. CREATANINE CLEARANCE AND GFR CALCULATOR: A online calculator which calulates creatanine clearance and GFR using several different estimates.


1. AVOID I.V. PROMETHIAZINE (PHENERGAN): Important educational resource for nurses advising to avoid administering I.V. promethiazine.

2. PROTECT PATIENTS FROM I.V. INFILTRATION: Article on ways in which to reduce I.V.  infiltration incidence and harm.